Danielle Pillsbury

Blog

Common Clinical Trial Disclosure Challenges & Potential Solutions

Pharmaceutical companies are being required to be more transparent through the timely disclosure of more…

Danielle Pillsbury2023 年 2 月 24 日

网络研讨会点播

FDA Modernization Act 2.0 — 它对药品开发人员意味着什么？

历史上，FDA 要求药物发现与开发项目必须包含动物试验。This…

Danielle Pillsbury2023 年 2 月 21 日

Conference

Lab of the Future USA

Conference: Lab of the Future USA Date: March 10-11, 2025 Location: Boston, MA Presenters: Nick…

Danielle Pillsbury2023 年 2 月 15 日

Conference

Asembia AXS25 Summit

April 27-2025 年 5 月 1 日 - Las Vegas, Nevada - Booth #1523

Danielle Pillsbury2023 年 2 月 15 日

Conference

ASCO Annual Meeting 2024

Danielle Pillsbury2023 年 2 月 15 日

会议

DIA Annual Meeting 2025

June 15-19, 2025 - Washington, DC - Booth #1831

Danielle Pillsbury2023 年 2 月 15 日

Conference

ISPOR 2025

May 13-16, 2025 - Palaise de Congress Montreal, Quebec, CA

Danielle Pillsbury2023 年 2 月 15 日

On-Demand Webinar

RAPS Sponsored: How Drug Developers Can Navigate the Inflation Reduction Act

The Inflation Reduction Act (enacted in August 2022) contains profound changes for the healthcare and…

Danielle Pillsbury2023 年 2 月 10 日

On-Demand Webinar

Data Visualization with SEND Data to See What Happened at the Preclinical Phase

SEND is an implementation of CDISC’s (Clinical Data Interchange Standards Consortium) SDTM (Study Data Tabulation…

Danielle Pillsbury2023 年 2 月 9 日

Podcast

Podcast 采访 Dr. Elvira Müller 欧盟联合 HTA - 已决定，但将如何执行，企业应如何准备

In Europe, there are at least as many reimbursement assessment processes in place as European…

Danielle Pillsbury2023 年 2 月 7 日

Danielle Pillsbury

Common Clinical Trial Disclosure Challenges & Potential Solutions

FDA Modernization Act 2.0 — 它对药品开发人员意味着什么？

Lab of the Future USA

Asembia AXS25 Summit

ASCO Annual Meeting 2024

DIA Annual Meeting 2025

ISPOR 2025

RAPS Sponsored: How Drug Developers Can Navigate the Inflation Reduction Act

Data Visualization with SEND Data to See What Happened at the Preclinical Phase

Podcast 采访 Dr. Elvira Müller 欧盟联合 HTA - 已决定，但将如何执行，企业应如何准备

订阅时事通讯

快捷链接

解决方案

联系我们